⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
QGEN News
QIAGEN N.V.
Global Microfluidics Market by Product Type, Application, End User, and Region, 2026-2036 | $48.04 Billion Opportunity Driven by Point-of-Care Diagnostics and Automation
globenewswire.com
A
TMO
QGEN
ILMN
LAB
DHR
ABT
BIO
Europe Point of Care Diagnostics Market Size and Forecast, 2021 - 2031 | Market to Reach US$21.4 Billion by 2031 as Rapid Testing and Molecular Innovation Drive 13.4% CAGR
globenewswire.com
ABT
BIO
QGEN
NDSN
GILD
Immunogenomics Market Size, Share, Trends, and Growth Forecast, 2026-2033 | NGS and Personalized Medicine Drive Market Toward USD 9.82 Billion at 5.97% CAGR
globenewswire.com
TMO
ILMN
QGEN
ROG
AGNC
BIO
PACB
ONT
CDNA
North America Laboratory Animal Medicine Market Size, Share, Trends, and Forecast, 2026-2033 | R&D Investment and GLP Adoption Propel Market to USD 5.18 Billion at 5.48% CAGR
globenewswire.com
MRK
ELAN
NEOG
TMO
QGEN
Global Precision Medicine Biotechnology Solutions Market - Strategic Insights and Forecasts, 2026-2031 | AI and Genomics Fuel 11.3% CAGR, Creating a $49.6 Billion Opportunity
globenewswire.com
PFE
NVS
AZN
TMO
BMY
AMGN
ILMN
QGEN
Magnetic Beads Market - Global Forecast and Growth Opportunities, 2026-2032 | Automation, Genomics, and Molecular Diagnostics Drive 7.91% CAGR Toward USD 6.18 Billion
globenewswire.com
TMO
BIO
DHR
QGEN
Global Magnetic Beads Market Size, Share, Trends, and Forecast by Type, Application, and Region, 2026-2034 | NGS and Diagnostics Drive 9.88% CAGR Toward USD 6.8 Billion
globenewswire.com
BIO
QGEN
TMO
Europe Non-Viral Transfection Reagents Market Forecast to 2035 by Method, Application, and End-User | mRNA and Cell Therapy Fuel 5.7% CAGR and USD 0.40 Billion Opportunity
globenewswire.com
QGEN
Australia Precision Genomics Market Size, Share, Trends and Forecast to 2035 | AI, NGS, and Public Funding Fuel 13.2% CAGR and a US$1.01 Billion Opportunity
globenewswire.com
TXG
AGNC
BGI
ILMN
ONT
PACB
QGEN
TMO
Global Residual DNA Testing Market Size, Share, Trends, and Forecast, 2026-2033 | Biologics and Gene Therapy Growth Fuels 6.8% CAGR to USD 525.3 Million
globenewswire.com
TMO
MRK
CRL
BIO
QGEN
MRVI